Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD to review Veterinary Medicines Regulations
The VMD is assessing the efficiency of the legislation.
It has called for evidence on the Medicines and Medical Devices Act 2021.

The Veterinary Medicines Directorate (VMD) has called for veterinary stakeholders to share evidence on the Medicines and Medical Devices Act 2021.

It comes as the agency examines the structure of the Veterinary Medicines Regulations 2013, assessing its efficiency in protecting animal and public health and the wider environment.

The VMR legislate the UK's veterinary medicines and medicated feeds, including their manufacture, advertising, supply, possession and administration. Under the Windsor Framework, there is separate legislation in Great Britain and in Northern Ireland.

The review hopes to evaluate how well it is meeting these goals, while also avoiding regulatory burden where possible. The VMD will consider where restructuring or consolidation will improve the clarity of VMR legislation and whether it can be better implemented.

The regulations originated from EU legislation, before it was transposed into UK law.

Under the Medicines and Medical Devices Act 2021, the UK has primary powers to amend the legislation where necessary. The UK also has a statutory obligation to assess the legislation and its impact at least once every five years.

The VMR were last amended by the Veterinary Medicines (Amendment, etc.) Regulations 2024.

To help inform the investigation, the VMD has asked that stakeholders share their views and experiences of the VMR. Where possible, the responses should include specific examples.

Although anyone can respond to the inquiry, the VMD has particularly welcomed responses from those involved with veterinary medicines, as well as veterinary surgeons, veterinary nurses and other suitably qualified persons. Farmers, professional animal keepers and pet owners are also invited to share evidence.

Responses can be submitted through the VMD's Citizen Space platform, or sent by email to vmr@vmd.gov.uk using the relevant call for evidence documents.

The call for evidence will close at 23:59 on 26 September 2025.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.